C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 333/36 (2006.01) A61K 31/341 (2006.01) A61K 31/381 (2006.01) A61K 31/4025 (2006.01) A61K 31/4152 (2006.01) A61K 31/4155 (2006.01) A61K 31/425 (2006.01) A61K 31/427 (2006.01) A61K 31/4436 (2006.01) C07D 207/34 (2006.01) C07D 231/38 (2006.01) C07D 275/02 (2006.01) C07D 409/04 (2006.01) C07D 409/12 (2006.01) C07D 417/12 (2006.01)
Patent
CA 2565519
The present invention is directed to a compound having the general structure of formula (1) useful for the treatment, prevention or amelioration of a CXCR1 or CXCR2 chemokine-mediated disease.
La présente invention concerne un composé dont la structure générale est représentée par la formule (1). Ce composé est utile pour le traitement, la prévention ou l'atténuation d'une maladie médiée par la chimiokine CXCR1 ou CXCR2.
Aki Cynthia J.
Chao Jianhua
Fine Jay
Lundell Daniel
Priestley Tony
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
Schering Corporation
LandOfFree
Cxcr1 and cxcr2 chemokine antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cxcr1 and cxcr2 chemokine antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cxcr1 and cxcr2 chemokine antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1867556